ClinicalTrials.gg
CompletedNCT02579577Updated May 3, 2017

Decision Making and Future Planning for Children With Complex Illness

An observational study in Long-Term Care and Palliative Care, sponsored by University of Nottingham. Completed at 3 sites in United Kingdom. Open to participants aged 28 Days and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-05-03.

Sponsored by University of Nottingham · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
32
Ages
28 Days and older
Sex
All
01

Study summary

The population of children with life-limiting illnesses (LLI) in England is increasing and there is growing need to improve the quality of children's palliative care. Families of children with LLI are confronted with many care decisions for their children, such as whether and when to commence artificial nutrition or ventilation. They may also have the opportunity to consider the care that may be appropriate for their child in the future. Despite the important decisions families and professionals are required to make, there is little empirical evidence regarding the process of decision making and future planning for this population. Few studies have investigated the perspectives of multiple stakeholders and none have addressed multiple perspectives longitudinally. Therefore the relational and contextual aspects of decision making and future planning for children with LLI have as yet not been identified.

A multiple embedded case study utilising ethnographic methods (semi-structured interviews, observation and notes review) is proposed to address this knowledge gap. Families of children with LLI cared for in either of two participating hospitals will be recruited and followed up for up to 12 months. The family will be invited to nominate 'significant others' (e.g. relatives, friends, health care professionals) who assist them in decision making and future planning, to participate in the study. Outpatient clinic appointments or ward rounds during periods of hospitalisation will be observed and semi-structured interviews will be conducted approximately three times with each participant. Medical notes will be reviewed at the end of the study.

This research will enable a better understanding of the experiences and preferences for engaging in decision making and future planning from the perspectives of all stakeholders. It will also provide an awareness of the communication practices involved in discussions and the networks of care surrounding children with LLI, including specific support needs in relation to their role.

02

Conditions studied

  • Long-Term Care
  • Palliative Care
03

In context

Lead sponsor

University of Nottingham is the lead sponsor of 463 studies on the registry; 78 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
28 Days and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Each case will be centred around a child with a life-limiting illness and their parents who will have been identified as eligible by their usual care team. Additional significant others who are important in their decision making and future planning will be identified by the family and will ideally include at least one health professional. However, the composition of each case will be determined by the child and family and may involve only them. Nominated 'significant others' may include extended family, peers, ministers of religion, key workers etc.

Eligibility criteria

Inclusion criteria - Parent

  • Their child must be between 28 days and 18 years old
  • Their child must have a LLI within categories 2-4 (Association for Children with Life-threatening and Terminal Conditions and their Families, 2004) (see page 8)
  • Child must be under the care of a consultant at either of the two NHS Trusts included in the study
  • The parent must be aware of the child's LLI diagnosis
  • Participants must speak English. This is both due to resource constraints and due to the sensitive topic such that difficulties in translating questions sensitively may cause greater distress to participants.

Inclusion criteria - Child

  • Children will be classed as participants if their parent is a participant and consents to their child's medical notes being accessed.
  • For children to participate in the interview component of the study, they must be over the age of 7 years and cognitively able to provide their own assent (or consent, if over 16 years old)
  • Parents must have agreed to the child's participation if they are under 16 years old
  • Participants must speak English or be able to communicate in some way using alternative or augmentative communication.

Inclusion criteria - Significant Others/Professionals

  • Significant others must have been identified by the eligible child and/or parents as being important in their decision making and future planning
  • Participants must speak English
  • Participants must be over the age of 7 years and provide their own assent alongside parental consent (if under 16 years old) or provide consent if they are over the age of 16 years (in the case of a friend or sibling being nominated as a 'significant other').

Exclusion Criteria:

  • Families and significant others of children with ACT Category 1 life-threatening illnesses (Conditions for which curative treatment may be feasible but can fail)
  • Participants who do not meet the inclusion criteria.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
32 participants (actual)
Patient registry
No

Groups and cohorts

  • Decision making cohort

    Any people identified as being important within the network of care for children with life-limiting illnesses.

    Other: Observation · Other: Interviews · Other: Medical notes review

Interventions

  • OtherObservation

    Observation of clinic appointments and ward rounds if the child is admitted to hospital during the study period.

  • OtherInterviews

    Semi-structured interviews will be conducted approximately 3 times during the study period with each participant.

  • OtherMedical notes review

    The child's electronic medical record will be accessed periodically to identify any planned appointments or periods of hospitalisation and their medical notes will also be reviewed at the end of the study.

06

What researchers measure

Primary outcomes

  1. Semi-Structured Interview Responses

    Interviews will be semi-structured, with a broad opening question asking the participant about the child at the centre of the case; both in terms of their illness and their context (family, personality, values and goals). Although the topics of decision making and future planning will be covered within the interview, the way in which these are initiated are likely to be different for each participant and asked in relation to the responses given to the opening question.

    Time frame: Up to 24 months

  2. Observational fieldnotes

    Observations will occur at clinic appointments and ward rounds and will aim to identify the communication processes involved in decision making and how each individual involved participates.

    Time frame: Up to 24 months

07

Study locations

3 sites
  • Sherwood Forest Hospitals NHS Trust
    Mansfield, United Kingdom
  • Nottingham University Hospitals NHS Trust
    Nottingham, United Kingdom
  • Sheffield Children's Hospital
    Sheffield, United Kingdom
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Oct 2015, a primary completion of Jan 2017 and a completion of Jan 2017. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 31, 2015
First posted
Oct 19, 2015
Start
Oct 2015
Primary completionActual
Jan 31, 2017
CompletionActual
Jan 31, 2017
Last update
May 3, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 3, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02579577
Responsible party
Sponsor
First posted
Oct 19, 2015
Start date
Oct 2015
Primary completion
Jan 31, 2017
Completion
Jan 31, 2017
Last update
May 3, 2017

Study contacts

Bridget Johnston, Professor
principal investigator · University of Nottingham

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion